|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Phase I study of sequential vaccinations with fowlpox-CEA (6D)-TRICOM alone and sequentially with vaccinia- CEA(6D)-TRICOM, with and without granulocytemacrophage colony-stimulating factor, in patients with carcinoembryonic antigen-expressing carcinomas 显示文摘 | Marshall J L Gulley J L Arlen P M | 2005 | J Clin Oncol2005，23，： | 1 |
| 2 | The use of a rapid ELISPOT assay to analyze peptide-specific immune responses I carcinoma patients to peptide vs recombinant poxvirus vaccines显示文摘 | Arlen P Tsang K Y Marshall J L | 2000 | Cancer Immunol Immunother2000，49，10： | 1 |
| 3 | A randomized phase IIstudy of concurrent docetaxel plus vaccine versus vaccine alone inmetastatic androgen-independent prostate cancer 显示文摘 | Arlen P M Gulley J L Parker C | 2010 | ClinCancer2010，12，： | 1 |
| 4 | PANVAC-VF: poxvi- ral-based vaccine therapy targeting CEA and MUC1 in carcinoma显示文摘 | Madan R A Arlen P M Gulley J L | 2007 | Expert Opin Biol Ther2007，7，4： | 1 |
| 5 | Random- ized phase 1I trial of docetaxel plus thalidomide in androgen independent prostate eancer显示文摘 | DAHUT W L GULLEY J L ARLEN P M | 2004 | J Clin Oneol2004，22，13： | 1 |
| 6 | Phase trial of bevacizumab, thalidomide, doeetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer 显示文摘 | NING Y M GULLEY J L ARLEN P M | 2010 | J Clin Oneol2010，28，12： | 1 |
| 7 | Randomized phase Ⅱ trial of docetaxel plus thalidomide in androgen-dindependent prostate cancer显示文摘 | Dahut W L Gulley J L Arlen P M | 2004 | J Clin Oncol2004，22，： | 1 |
| 8 | A randomized phase Ⅱ study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer 显示文摘 | Arlen P M Gulley J L Parker C | 2006 | Clin Cancer Res2006，12，： | 1 |
| 9 | Randomized phase II trial of docetaxel plus thalidomide in androgen-independent prostate cancer显示文摘 | Dahut W L Gulley J L Arlen P M | 2004 | Journal of Clinical Oncology2004，22，13： | 1 |
| 10 | Therapeutic vaccines for prostate cancer:a review of clinical data显示文摘 | Arlen P M Gulley J L | 2005 | Curr Opin Investig Drugs2005，6，6： | 1 |
| 11 | A randomized phase Ⅱ trial of docetaxel plus thalidomide in androgenindependent prostate cancer显示文摘 | Dahut W L Arlen P M Gulley J | 2002 | Proc Am Soc Clin On col2002，21，： | 1 |
| 12 | Response of soil microbial biomass and community composition to chronic nitrogen additions at Harvard forest显示文摘 | COMPTON J E LIDIA S W ARLENE L P | 2004 | Forest Ecology and Management2004，196，： | 1 |
| 13 | Phase 1I trial of bevacizumab, thalidomide, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer显示文摘 | NING Y M GULIEY J L ARLEN P M | 2010 | J Clin Oncol2010，28，12： | 1 |
| 14 | Phase I study of sequential vaccinations with fowlpox-CEA(6D)-TRICOM alone and sequentially with vaccinia-CEA(6D)-TRICOM,with and without granulocyte-macrophage colony-stimulating factor,in patients with carcinoembryonic antigen-expressing carcinomas显示文摘 | MARSHALL J L GULLEY J L ARLEN P M | 2005 | J Clin Oncol2005，23，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员